Fixation time does not affect expression of HER2/neu

American Journal of Clinical Pathology

Volumn 135, Issue 3, 2011, Pages 484-

  Goldsmith, Jeffrey D ^a   Allred, D Craig ^b   Beasley, Mary Beth ^c   Eisen, Richard ^d   Fulton, Regan S ^e   Gown, Allen M ^f   Hammond, M Elizabeth H ^g  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d GREENWICH HOSPITAL   (United States)

^e KAISER PERMANENTE   (United States)

^f PHENOPATH LABORATORIES   (United States)

^g INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIXATIVE; FORMALDEHYDE;

BREAST CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; BREAST TUMOR; FEMALE; METABOLISM; METHODOLOGY; NOTE; PATHOLOGY; PILOT STUDY; STAINING; TIME; TISSUE FIXATION;

BREAST NEOPLASMS; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; PILOT PROJECTS; RECEPTOR, ERBB-2; STAINING AND LABELING; TIME FACTORS; TISSUE FIXATION;

EID: 79954444694     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPO1ZG6FERBGZB     Document Type: Letter

References (2)

1. Ibarra JA, Rogers LW. Fixation time does not affect expression of HER2/neu: a pilot study. Am J Clin Pathol. 2010;134:594-596.
2. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18-43.